15 June 2012, Valby, Danemark- Lundbeck is set to cut 600 commercial positions as part of major restructuring efforts to cope with the patent loss of its antidepressant Lexapro (escitalopram) as well as tough economic conditions.
http://www.pmlive.com/pharma_news/lundbeck_cuts_600_sales_jobs_europe_407892
